Purdue Pharma Offers Plan to End Sackler Control and Mounting Lawsuits by BY JAN HOFFMAN AND MARY WILLIAMS WALSH


The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.

Published: March 16, 2021 at 05:11AM

from NYT Health https://ift.tt/3cAb56i